Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Physics
Class Information
Number: 376/141
Name: Induced nuclear reactions: processes, systems, and elements > Nuclear fusion > Magnetic confinement of plasma > Linear confinement > Mirror devices > Plasma formed or contained between spaced electrodes
Description: Subject matter wherein the plasma is bounded on two sides by electric charge-carrying conductors.










Patents under this class:

Patent Number Title Of Patent Date Issued
8175209 Method and apparatus for pulsed power generation May. 8, 2012
7656989 Electromagnetic pulse transmitting system and method Feb. 2, 2010
7634042 Pulsed power system including a plasma opening switch Dec. 15, 2009
7340025 Plasma antenna generator and method of using same Mar. 4, 2008
4584160 Plasma devices Apr. 22, 1986
4347621 Trochoidal nuclear fusion reactor Aug. 31, 1982
4156832 Gas vortex with MHD-drive May. 29, 1979











 
 
  Recently Added Patents
Wrench
Creating and manufacturing documents that initially exceed equipment finishing capacity
Animation control apparatus, animation control method, and non-transitory computer readable recording medium
Radiation-curable ink composition, ink jet recording method, and recorded matter
Phase-amplitude 3-D stereo encoder and decoder
Case for electronic device
Display screen or portion thereof with graphical user interface
  Randomly Featured Patents
Face protector
Semiconductor integrated circuit device and method of manufacturing the same
Platelet endothelial cell adhesion molecule-1 promoters and uses thereof
Method for using a pump set having secure loading features
Water soluble azoles as broad-spectrum antifungals
Photoelectrographic imaging with near-infrared sensitizing dyes
Optimizing performance of instructions based on sequence detection or information associated with the instructions
Method for manufacturing metal nanoparticles comprising rod-shaped nanoparticles
Cassette for loading substrate
Imidazopyridazines as PAR1 inhibitors, production thereof, and use as medicaments